Chinese Patent Attorney Real Workflow: From Invention Disclosure to CNIPA Filing

China is the world's largest patent-filing jurisdiction. CNIPA (China National Intellectual Property Administration) receives over 1.6 million patent applications annually, topping global rankings for more than a decade. Yet many international IP firms' understanding of Chinese practice stops at "refer the matter to a local agent," with little grasp of what a Chinese patent agent's day-to-day practice actually looks like.

That knowledge gap carries real costs: misapplying the three-track patent system (invention/utility model/design), missing the substance of the 2024-01-20 regulatory triple update, triggering red lines on genetic resource disclosure and confidentiality review obligations, or miscalculating the PCT China national phase deadline of 30 months (extendable to 32).

This article reconstructs the complete Chinese patent agent workflow—from invention disclosure form to cponline submission—drawing on the Patent Law (4th amendment, 2020), the Implementing Regulations (revised 2023, effective 2024-01-20), the Patent Examination Guidelines (2023, CNIPA Order No. 78), and CNIPA Announcement No. 594.

Target readers: International IP firm partners who need a systematic grasp of Chinese practice; corporate IP directors responsible for cross-border patent strategy; Chinese patent agents looking to benchmark against best practices.

---

1. Filing Document Checklist

Chinese patent documents vary significantly by patent type. Understanding the three-track structure is essential.

Mandatory Documents (Invention Patent)

No.	Document	Role	Notes
1	Request Form (Official Form 100101)	Main application form	Includes genetic resource/novelty grace period declaration fields
2	Claims	Defines the scope of patent protection	At least 1 independent claim; numbered sequentially in Arabic numerals
3	Description / Specification	Core technical content document	Mandatory 5-section structure (see Chapter 3)
4	Drawings	Supplements the technical solution	Required for mechanical/electrical/process inventions
5	Abstract	Technical summary	≤ 300 characters (including punctuation); accompanied by abstract figure

Three-Track Patent System Comparison

Item	Invention Patent	Utility Model	Design Patent
Subject matter	Products/methods/uses	Products only (shape, structure, or combination)	Product appearance (including partial design, new in 2021)
Examination	Formal + substantive examination	Formal + obvious creativity review (new 2024)	Formal examination only
Term	20 years from filing date	10 years from filing date	15 years from filing date (was 10 years before 2021 reform)
Typical grant timeline	15–36 months	4–6 months (fast-track: 1 month)	4–6 months

Conditionally Mandatory Documents

Document	Trigger	Deadline
Power of Attorney (Form 100021)	Engaging a patent agency (mandatory for foreign applicants)	At filing or supplemented within 2 months
Priority Documents	Claiming foreign priority (Paris Convention)	Within 3 months of filing date
Novelty grace period evidence	Claiming Art. 24 exception (international exhibition / academic conference / unauthorized disclosure)	Declaration with application; evidence within 2 months of filing
Genetic Resource Disclosure Form	Invention completed using Chinese genetic resources	Simultaneously with application
Confidentiality Review Request	Invention completed in China with foreign filing plans	Before filing abroad — file with CNIPA first
Sequence Listing (WIPO ST.26 XML)	Nucleotide/amino acid sequences	Simultaneously with application
Fee Reduction Request + Evidence	Claiming fee reduction	Simultaneously with application

---

2. The Real Patent Agent Workflow (End-to-End)

Phase A: Pre-Filing

A1. Client Consultation (Day 0–1)

• Agent: Preliminary patentability assessment (does it fall under Art. 25 excluded subject matter: scientific discoveries, rules for mental activities, diagnostic/treatment methods?); inquire about prior disclosures (China's novelty grace period only covers the 4 specific scenarios in Art. 24 — it is not a general grace period); assess which patent type(s) to file (invention vs. utility model vs. design vs. double-filing).

A2. Engagement and Fee Proposal (Days 1–3)

Execute agency contract (CNIPA 2025-01 model text) and power of attorney (Form 100021); issue fee proposal (official fees at cost + tiered agency fees).

A3. Disclosure Meeting and IDF Distribution (Days 3–10)

• Agent: Distribute the Invention Disclosure Form (IDF) template; arrange inventor interviews (standard 1–2 hours; complex fields 3–5 hours); use probing interview technique to extract: problem–solution–effect triad, alternative embodiments, broader/narrower concepts.
• Inventor: Complete the IDF, attach experimental data, drawings, comparative testing.

A4. Prior Art Search (Days 3–7)

Search tools: CNIPA Patent Search and Analysis Platform (primary tool for domestic search); commercial tools Incopat/PatSnap/Himmpat; English-language search via USPTO/EPO/WIPO.

Key CN–US difference: Chinese clients typically expect the agent to deliver an explicit patentability conclusion before drafting begins — this is one of the most important practical distinctions between Chinese patent agents and US patent attorneys.

---

Phase B: Drafting

B1. Claims Drafting (Days 5–15)

• Identify the "minimum inventive unit" of the inventive concept for the independent claim.
• Use the two-part claim structure: preamble (title and technical features shared with closest prior art) + characterizing portion introduced by "characterized in that" (审查员默认偏好 / the examiner's preferred format).
• Multiple dependent claims may only reference prior claims in the alternative, and cannot serve as the base for another multiple dependent claim (Implementing Regulations Art. 22; violation triggers a formal examination objection).

B2. Specification Drafting (Days 5–15)

Mandatory 5-section structure (see Chapter 3). Mandatory paragraph numbering from [0001]. All five sections must be present. Three core principles:

• Background Art: Objective description; do not disparage others' patents; cited prior art documents must include publication number and publication date.
• Summary of Invention: Must contain all three sub-modules: technical problem + technical solution + beneficial effects.
• Detailed Description: At least 1 embodiment; complex inventions need 2–3+; disclosure sufficient for a person skilled in the art to practice the invention (Art. 26(3)).

B3–B4. Drawings/Abstract and Client Review (Days 2–7)

Prepare drawings (Chinese figure labels: "图 1", "图 2" — never "Fig. 1"); draft abstract (≤ 300 characters); select abstract figure; send to client for 1–2 rounds of review before finalization.

---

Phase C: Filing

• Primary channel: Patent Business Office System (cponline.cnipa.gov.cn); requires electronic application CA certificate login.
• Application number format: 2024 1 0123456.7 (3rd digit: 1=invention, 2=utility model, 3=design).
• Fee payment deadline: Within 2 months of filing date, or within 15 days of receiving the acceptance notice; fee reduction applicants must apply for reduction before paying.

---

Phase D: Examination

Stage	Invention	Utility Model
Formal examination	1–3 months; enters 18-month publication period	2–6 months; includes obvious creativity review since 2024
Substantive examination request	Within 3 years of filing date; failure = deemed withdrawal	—
First OA response period	4 months (new rule from 2024-01-20)	—
Subsequent OA response periods	2 months	—
Appeal of rejection	Within 3 months of receiving rejection decision	Within 3 months

Core OA response strategy: Focus on inventive step (Art. 22(3)) as the primary battleground; apply the three-step analysis (identify closest prior art → determine distinguishing features and actual technical problem → assess non-obviousness); amendments must not go beyond the scope of the original description and claims (Art. 33 — the primary red line for AI-assisted drafting).

---

3. CN-Specific Format Requirements

1. Mandatory 5-Section Specification Structure

Technical Field         ← starts at [0001]
Background Art          ← objective description of prior art and technical problems
Summary of Invention    ← technical problem + technical solution + beneficial effects (all 3 required)
Brief Description of Drawings ← figure-by-figure annotation
Detailed Description    ← at least 1 complete working embodiment

2. Mandatory Paragraph Numbering [0001]

• All specification body paragraphs must be numbered sequentially with 4-digit Arabic numerals starting from [0001].
• Not numbered: invention title, the five section headings themselves, tables and figures.
• Claims, abstract, and drawings each have their own numbering system and do not use paragraph numbers.
• OA amendments add new paragraphs at the end with continuing sequential numbers.

3. Two-Part Claim Format

Recommended independent claim format:

A [subject matter], comprising/consisting of...,
characterized in that [distinguishing technical features over closest prior art].

4. Drawing Conventions

• Figure labels must use Chinese format: "图 1", "图 2" (not "Fig. 1").
• Black-and-white line drawings are the norm; reference signs must be consistent throughout the application.
• Resolution ≥ 300 dpi; clear for reproduction.

5. Abstract Requirements

• Length: ≤ 300 characters (including punctuation).
• Content: technical field + technical problem + main technical features + utility.
• Commercial promotional language is prohibited.

---

4. CN-Unique Institutions

Double-Filing (Simultaneous Invention + Utility Model Application)

• Legal basis: Patent Law Art. 9(1); Implementing Regulations Art. 48.
• Conditions: Same applicant; same inventive concept; same date (same filing date, not priority date); separate declarations in each request form.
• Strategic value: Utility model typically granted in 4–6 months, providing an immediate enforcement tool ("transitional protection"); when the invention is later granted, the applicant declares abandonment of the utility model to receive 20-year protection.
• 2024 amendment: Clarified that abandonment is the only mechanism — modifying invention claims to avoid double-patenting is no longer permitted.

Confidentiality Review (Patent Law Art. 19)

• Obligation triggered: Any entity or individual that files a patent abroad (including PCT) for an invention or utility model completed in China must first obtain confidentiality review clearance from CNIPA.
• Review timeline: Decision within 4 months; extendable by 2 months for complex cases.
• Consequences of violation: The corresponding Chinese application will not be granted; granted patents may be invalidated.

Genetic Resource Disclosure (Patent Law Art. 26(5))

• Disclosure requirement: Inventions completed using Chinese genetic resources must disclose both the direct source (the channel through which the genetic resource was obtained) and the original source (the geographic origin of the genetic resource in nature).
• 2024 enhancement: The scope of "genetic resources" was expanded to include "genetic information derived from such materials" (aligned with WIPO GRATK Treaty trends).
• Consequences: Non-disclosure or false disclosure → no grant; granted patents may be invalidated.

Prioritized Examination and IP Protection Center Fast Track

Channel	Eligibility	Effect
Prioritized Examination	National key industries; internet/big data/AI; major R&D projects	Invention: within 1 year; utility model: 2 months; design: 1 month
IP Protection Centers (60 nationwide)	Registered enterprises/universities; application must fall within center's industry scope	Invention: 3–6 months; utility model: 1 month; design: 5–7 working days

Patent Term Extension (New Institution from 2021)

• PTA (prosecution delay): For invention patents granted more than 4 years after filing and 3 years after substantive examination request, applicants may request compensation for unreasonable CNIPA-caused delays.
• PTE (drug approval delay): For invention patents related to innovative drugs receiving Chinese marketing approval, maximum 5-year extension; total effective term not to exceed 14 years from approval date.
• Request deadline: Within 3 months of grant publication.

PCT China National Phase

Item	Detail
Standard deadline	30 months from priority date (Implementing Regulations Art. 108)
Extension	Pay CNY 1,000 surcharge to extend to 32 months (unlike USPTO/JPO, this option exists)
Translation	Chinese translation due within the deadline; translation going beyond original text triggers correction
Rights restoration	CNIPA accepts rights restoration applications (unlike KIPO)

---

5. Key Articles and Deadlines Quick Reference

Event	Deadline	Legal Basis
Substantive examination request	Within 3 years of filing date	Patent Law Art. 35
Publication of invention application	18 months from filing (early publication available)	Patent Law Art. 34
First OA response	4 months (from 2024-01-20)	Implementing Regulations
Subsequent OA responses	2 months	Implementing Regulations
OA extension requests	1 or 2 months; generally 1 time only; no extension for final notification	Implementing Regulations
Appeal of rejection decision	3 months from receiving rejection	Patent Law Art. 41
Paris Convention priority (invention/utility model)	12 months	Patent Law Art. 29
Paris Convention priority (design)	6 months	Patent Law Art. 29
Priority document submission	Within 3 months of filing date	Implementing Regulations Art. 36
PCT national phase entry	30 months (extendable to 32 months)	Implementing Regulations Art. 108
Registration formalities after grant	Within 2 months of grant notice	Patent Law Art. 39/40
Annuity grace period	6 months after due date (with surcharge)	Implementing Regulations
Patent term extension request	Within 3 months of grant publication	Patent Law Art. 42

---

6. Fee Schedule (2024 Updated)

Official Fees (Filing Stage, RMB)

Item	Invention	Utility Model	Design
Filing fee	900	500	500
Publication printing fee	50	—	—
Substantive examination fee	2,500	—	—
Excess claims fee (per claim over 10)	150	150	—
Excess specification pages (per page over 30)	50	50	—

Fee Reduction Policy (CNIPA Announcement No. 594, 2024)

Category	Eligibility	Single applicant reduction	Multiple applicants reduction
Individuals	Previous year monthly income ≤ RMB 3,500 (annual ≤ RMB 42,000)	85%	70%
SMEs	Previous year taxable income ≤ RMB 1,000,000	85%	70%
Universities/Research institutions	Meeting conditions in CNIPA Announcement No. 594	85%	70%

Eligible fees: filing fee, publication printing fee, substantive examination fee, years 1–3 annuities.

---

7. CN vs. US/JP/KR Key Differences

Item	China (CN)	United States (US)	Japan (JP)	Korea (KR)
Patent types	3 (invention/utility model/design)	3 (utility/design/plant)	2 (特許/実用新案)	2 (특허/실용신안)
Utility model creativity review	Obvious creativity check since 2024	N/A	Not included	Not included
Confidentiality review	Art. 19 (mandatory)	No equivalent	None	None
Genetic resource disclosure	Art. 26(5) (mandatory)	No equivalent	No equivalent	No equivalent
PCT national phase deadline	30 months (extendable to 32)	30 months	30 months	31 months
First OA response period	4 months (2024 new rule)	3 months	60 days	3 months
Double-filing	Permitted (Art. 9)	Not permitted	Not permitted	Not permitted
Paragraph numbering	[0001] mandatory	Not required	【0001】mandatory	【0001】mandatory
Multiple dependent claims	Prohibited as base for another multiple dependent	Permitted (with surcharge)	Entirely prohibited	Prohibited since 2022
Novelty grace period	6 months, only 4 specific scenarios	12 months (broader under AIA)	12 months	12 months

---

8. AI Tools in Chinese Patent Agent Practice

Where AI Can Add Deep Value

Feature	Description	Priority
5-section completeness check	Auto-detect whether all 5 mandatory sections (technical field / background / summary / drawings / detailed description) are present	Core
Support requirement check	Verify that technical terms in the claims have corresponding embodiment support in the specification (Art. 26(4))	Core
Multiple dependent claim violation detection	Identify claims referencing multiple dependent claims as their base; flag violations	Core
Paragraph numbering [0001] auto-insertion	Auto-generate sequential 4-digit numbering for all specification body paragraphs	Core
Terminology consistency check	Confirm same technical features use identical terminology between specification and claims	Core
Three-step analysis assistance	Generate OA response argumentation framework based on distinguishing features	High
Confidentiality review risk alert	When inventor is in China with foreign filing plans, trigger Art. 19 obligation warning	High
Genetic resource disclosure trigger	When invention description involves biological materials, prompt disclosure obligation	High
Fee reduction eligibility diagnosis	Auto-calculate reduction percentage based on applicant type and financial status	Medium
PPH eligibility assessment	CN-US/CN-JP/CN-KR/PCT-PPH pathway analysis	Medium
Abstract figure recommendation	Suggest best representative figure based on invention type	Medium

Where AI Must Not Operate (Patent Agent Exclusive Domain)

Matter	Reason
Power of attorney and agency contract execution	Legal authorization acts requiring actual signatures
Final confidentiality review request and submission	Classified information judgment requires professional assessment; severe legal consequences
Substantive determination of genetic resource origin	Requires face-to-face confirmation with inventors
Official filing via cponline CA certificate account	Electronic signature act; must be performed by applicant or agency directly
Inventor PII (ID numbers, etc.) storage and processing	Subject to Personal Information Protection Law
Patentability opinions and FTO analysis	Legal advice requiring registered patent agent/attorney signature
Strategic amendment finalization in OA responses	Art. 33 scope determination is the agent's responsibility

CNIPA.AI's positioning: Focus on assisting patent agents with the most time-consuming core work — "technical content drafting" — from IDF information extraction to claims drafting, specification section generation, 5-section completeness checking, paragraph number auto-insertion, and multiple dependent claim violation detection. Inventor PII contained in the request form is handled within the patent agent's own systems and does not enter the CNIPA.AI platform.

---

Conclusion

Chinese patent agents work at the intersection of CNIPA's strict format requirements (5-section specification, [0001] numbering), unique institutional design (three-track patent system, double-filing, confidentiality review, genetic resource disclosure), and regulatory updates that arrive every few years in coordinated legislative bundles.

The 2024-01-20 regulatory triple update — utility model obvious creativity review, OA response period consolidated to 4 months, genetic resources expanded to include genetic information — represents the most significant practical shift in years. International IP firms that miss these changes will find themselves making avoidable errors.

The Claims First drafting philosophy holds in China as elsewhere; correct 5-section structure execution and accurate paragraph numbering are the foundation of quality deliverables. Leveraging AI assistance on these tool-ready, rule-based aspects is every patent agent's most practical path to higher efficiency — while legal judgment and PII handling must always remain in the patent agent's own hands.